findmyKOL
Clinical trialNCT07575269RecruitingInterventional

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

SponsorBoston Scientific CorporationEnrollment571Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial Fibrillation
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial fibrillation (PersAF). The main question it aims to answer is: Is the FARAFLEX Mapping and PFA System a safe and effective treatment for patients? Participants will undergo an ablation procedure using the FARAFLEX Mapping and PFA System.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Ireland
  • Mater Private Hospital-Hospital

    Dublin, Dublin, Ireland

    Garbor Szeplaki
    Recruiting
United States
  • Arrhythmia Research Group

    Jonesboro, Arkansas, United States

    Devi Nair →
    Recruiting
  • Emory Saint Joseph'S Hospital

    Atlanta, Georgia, United States

    David DeLurgio
    Recruiting
  • Mount Sinai Medical Center-Hospital

    New York, New York, United States

    Mohit Turagam →
    Recruiting
  • Texas Cardiac Arrhythmia Research

    Austin, Texas, United States

    Andrea Natale, MD
    Recruiting
  • Christus Trinity Mother Frances Health System-Hospital

    Tyler, Texas, United States

    Stanislav Weiner
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Jul 2026
Primary completion
20 Jul 2028
Completion
1 Jan 2030
Last update posted
6 Aug 2026
Registered enrollment
571
Registry id
NCT07575269
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.